RSV-specific binding molecules and means for producing them
US10730931B2 · kind B2 · utility
3Cited by
118References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2018 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Jul 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, and means and methods for producing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.